Avian flu vaccine developed for poultry

Dec 07, 2006

U.S. scientists say they've developed the first egg-injected vaccine to protect chickens against the avian influenza virus.

An Auburn University veterinary professor, Haroldo Toro, and researchers at Vaxin Inc. of Birmingham, Ala., say the vaccine would provide 100 percent protection once an outbreak's specific viral strain is identified.

"We have proven the principle, which is the major step in leading to commercially produced vaccine that could be vital to the poultry industry," Toro said. "When an outbreak occurs, we would determine the strain and quickly create a vaccine within three months specifically for it."

The researchers inserted a gene from a low pathogenic avian flu virus strain (H5N9) into a non-replicating human virus, a Vaxin proprietary technology, which was then injected into developing chicken embryos still in the egg.

When protection induced by the vaccine was tested against two highly pathogenic avian flu viruses -- a Vietnam H5N1 strain and a Mexican H5N2 strain -- the results showed 68 percent and 100 percent protection, in that order.

"Our results indicate that we can provide effective protection against any strain after incorporating the gene of the field strain into our vaccine construct," said Toro.

Copyright 2006 by United Press International

Explore further: Japan first nation to approve Novartis psoriasis drug

add to favorites email to friend print save as pdf

Related Stories

X-rays show how flu antibody binds to viruses

Dec 09, 2014

An important study conducted in part at the Department of Energy's SLAC National Accelerator Laboratory may lead to new, more effective vaccines and medicines by revealing detailed information about how a ...

Researchers use microRNA to trap mutant viruses in the lab

Aug 12, 2013

(Phys.org) —It's a scenario straight out of a sci-fi horror flick. Scientists take a deadly virus that people can only catch from birds and genetically engineer it so we can give it to each other. Unfortunately, ...

Recommended for you

Express Scripts turns to AbbVie in huge hepatitis C deal

Dec 22, 2014

The nation's largest pharmacy benefits manager is throwing its weight into the fight over high-cost hepatitis C drugs with a coverage restriction that might ultimately lower prices and improve patient access ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.